Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2037K) PPT slides of all figures Supplemental Material Index Related biobytes podcast Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Goepfert, P. A. Articles by Hunter, E. Search for Related Content PubMed PubMed Citation Articles by Goepfert, P. A. Articles by Hunter, E. Related Collections Related Article Related In this Issue article Social Bookmarking                            What's this?

¹ Department of Medicine, ² Department of Microbiology, and ³ Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294
⁴ Emory Vaccine Center at Yerkes National Primate Research Center, Atlanta, GA 30322
⁵ Department of Pediatrics, The Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, England, UK
⁶ Microsoft Research, Redmond, WA 98052
⁷ Department of Computer Science and Engineering, University of Washington, Seattle, WA 98195
⁸ Department of Pathology and Laboratory Medicine and ⁹ Department of Global Health, Emory University, Atlanta, GA 30322
¹⁰ Los Alamos National Laboratory, Los Alamos, NM 87545
¹¹ Zambia-Emory HIV Research Group, Lusaka, Zambia
¹² HIV Pathogenesis Program, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4013, South Africa
¹³ Partners AIDS Research Center, Massachusetts General Hospital, Charlestown, MA 02129

CORRESPONDENCE Paul A. Goepfert: paulg{at}uab.edu

In a study of 114 epidemiologically linked Zambian transmission pairs, we evaluated the impact of human leukocyte antigen class I (HLA-I)–associated amino acid polymorphisms, presumed to reflect cytotoxic T lymphocyte (CTL) escape in Gag and Nef of the virus transmitted from the chronically infected donor, on the plasma viral load (VL) in matched recipients 6 mo after infection. CTL escape mutations in Gag and Nef were seen in the donors, which were subsequently transmitted to recipients, largely unchanged soon after infection. We observed a significant correlation between the number of Gag escape mutations targeted by specific HLA-B allele–restricted CTLs and reduced VLs in the recipients. This negative correlation was most evident in newly infected individuals, whose HLA alleles were unable to effectively target Gag and select for CTL escape mutations in this gene. Nef mutations in the donor had no impact on VL in the recipient. Thus, broad Gag-specific CTL responses capable of driving virus escape in the donor may be of clinical benefit to both the donor and recipient. In addition to their direct implications for HIV-1 vaccine design, these data suggest that CTL-induced viral polymorphisms and their associated in vivo viral fitness costs could have a significant impact on HIV-1 pathogenesis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Crippling HIV one mutation at a time

Todd M. Allen and Marcus Altfeld
J. Exp. Med. 2008 205: 1003-1007. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• McKinnon, L. R., Capina, R., Peters, H., Mendoza, M., Kimani, J., Wachihi, C., Kariri, A., Kimani, M., Richmond, M., Kiazyk, S. K., Fowke, K. R., Jaoko, W., Luo, M., Ball, T. B., Plummer, F. A. (2009). Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1 p24. J. Virol. 83: 12636-12642 [Abstract] [Full Text]  
• Thobakgale, C. F., Prendergast, A., Crawford, H., Mkhwanazi, N., Ramduth, D., Reddy, S., Molina, C., Mncube, Z., Leslie, A., Prado, J., Chonco, F., Mphatshwe, W., Tudor-Williams, G., Jeena, P., Blanckenberg, N., Dong, K., Kiepiela, P., Coovadia, H., Ndung'u, T., Walker, B. D., Goulder, P. J. R. (2009). Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection. J. Virol. 83: 10234-10244 [Abstract] [Full Text]  
• Schneidewind, A., Tang, Y., Brockman, M. A., Ryland, E. G., Dunkley-Thompson, J., Steel-Duncan, J. C., St. John, M. A., Conrad, J. A., Kalams, S. A., Noel, F., Allen, T. M., Christie, C. D., Feeney, M. E. (2009). Maternal Transmission of Human Immunodeficiency Virus Escape Mutations Subverts HLA-B57 Immunodominance but Facilitates Viral Control in the Haploidentical Infant. J. Virol. 83: 8616-8627 [Abstract] [Full Text]  
• Peut, V., Campbell, S., Gaeguta, A., Center, R. J., Wilson, K., Alcantara, S., Fernandez, C. S., Purcell, D. F. J., Kent, S. J. (2009). Balancing Reversion of Cytotoxic T-Lymphocyte and Neutralizing Antibody Escape Mutations within Human Immunodeficiency Virus Type 1 Env upon Transmission. J. Virol. 83: 8986-8992 [Abstract] [Full Text]  
• Geldmacher, C., Metzler, I. S., Tovanabutra, S., Asher, T. E., Gostick, E., Ambrozak, D. R., Petrovas, C., Schuetz, A., Ngwenyama, N., Kijak, G., Maboko, L., Hoelscher, M., McCutchan, F., Price, D. A., Douek, D. C., Koup, R. A. (2009). Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. Blood 114: 1553-1562 [Abstract] [Full Text]  
• Saez-Cirion, A., Sinet, M., Shin, S. Y., Urrutia, A., Versmisse, P., Lacabaratz, C., Boufassa, F., Avettand-Fenoel, V., Rouzioux, C., Delfraissy, J.-F., Barre-Sinoussi, F., Lambotte, O., Venet, A., Pancino, G., for the ANRS EP36 HIV Controllers Study Group, (2009). Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses. J. Immunol. 182: 7828-7837 [Abstract] [Full Text]  
• Schneidewind, A., Brumme, Z. L., Brumme, C. J., Power, K. A., Reyor, L. L., O'Sullivan, K., Gladden, A., Hempel, U., Kuntzen, T., Wang, Y. E., Oniangue-Ndza, C., Jessen, H., Markowitz, M., Rosenberg, E. S., Sekaly, R.-P., Kelleher, A. D., Walker, B. D., Allen, T. M. (2009). Transmission and Long-Term Stability of Compensated CD8 Escape Mutations. J. Virol. 83: 3993-3997 [Abstract] [Full Text]  
• Crawford, H., Lumm, W., Leslie, A., Schaefer, M., Boeras, D., Prado, J. G., Tang, J., Farmer, P., Ndung'u, T., Lakhi, S., Gilmour, J., Goepfert, P., Walker, B. D., Kaslow, R., Mulenga, J., Allen, S., Goulder, P. J.R., Hunter, E. (2009). Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. JEM 206: 909-921 [Abstract] [Full Text]  
• Prado, J. G., Honeyborne, I., Brierley, I., Puertas, M. C., Martinez-Picado, J., Goulder, P. J. R. (2009). Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein. J. Virol. 83: 1018-1025 [Abstract] [Full Text]  
• Gray, C. M., Mlotshwa, M., Riou, C., Mathebula, T., de Assis Rosa, D., Mashishi, T., Seoighe, C., Ngandu, N., van Loggerenberg, F., Morris, L., Mlisana, K., Williamson, C., Karim, S. A., on behalf of the CAPRISA 002 Acute Infection Study, (2009). Human Immunodeficiency Virus-Specific Gamma Interferon Enzyme-Linked Immunospot Assay Responses Targeting Specific Regions of the Proteome during Primary Subtype C Infection Are Poor Predictors of the Course of Viremia and Set Point. J. Virol. 83: 470-478 [Abstract] [Full Text]  
• Miura, T., Brockman, M. A., Brumme, Z. L., Brumme, C. J., Pereyra, F., Trocha, A., Block, B. L., Schneidewind, A., Allen, T. M., Heckerman, D., Walker, B. D. (2009). HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1. J. Virol. 83: 140-149 [Abstract] [Full Text]  
• Brumme, Z. L., Brumme, C. J., Carlson, J., Streeck, H., John, M., Eichbaum, Q., Block, B. L., Baker, B., Kadie, C., Markowitz, M., Jessen, H., Kelleher, A. D., Rosenberg, E., Kaldor, J., Yuki, Y., Carrington, M., Allen, T. M., Mallal, S., Altfeld, M., Heckerman, D., Walker, B. D. (2008). Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection. J. Virol. 82: 9216-9227 [Abstract] [Full Text]  
• Matthews, P. C., Prendergast, A., Leslie, A., Crawford, H., Payne, R., Rousseau, C., Rolland, M., Honeyborne, I., Carlson, J., Kadie, C., Brander, C., Bishop, K., Mlotshwa, N., Mullins, J. I., Coovadia, H., Ndung'u, T., Walker, B. D., Heckerman, D., Goulder, P. J. R. (2008). Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point. J. Virol. 82: 8548-8559 [Abstract] [Full Text]  
• Bailey, J. R., O'Connell, K., Yang, H.-C., Han, Y., Xu, J., Jilek, B., Williams, T. M., Ray, S. C., Siliciano, R. F., Blankson, J. N. (2008). Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor. J. Virol. 82: 7395-7410 [Abstract] [Full Text]  
• Allen, T. M., Altfeld, M. (2008). Crippling HIV one mutation at a time. JEM 205: 1003-1007 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS